124 related articles for article (PubMed ID: 10856487)
1. Seminal plasma characteristics as indicators of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in men with obstructive azoospermia.
von Eckardstein S; Cooper TG; Rutscha K; Meschede D; Horst J; Nieschlag E
Fertil Steril; 2000 Jun; 73(6):1226-31. PubMed ID: 10856487
[TBL] [Abstract][Full Text] [Related]
2. [Mutations and polymorphisms in CFTR genes in infertile men with oligospermia or azoospermia].
Kusić J; Radojković D; Maletić V; Branković S; Savić A
Srp Arh Celok Lek; 2002; 130(1-2):1-6. PubMed ID: 12073281
[TBL] [Abstract][Full Text] [Related]
3. Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling.
Daudin M; Bieth E; Bujan L; Massat G; Pontonnier F; Mieusset R
Fertil Steril; 2000 Dec; 74(6):1164-74. PubMed ID: 11119745
[TBL] [Abstract][Full Text] [Related]
4. Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia.
Mak V; Zielenski J; Tsui LC; Durie P; Zini A; Martin S; Longley TB; Jarvi KA
JAMA; 1999 Jun; 281(23):2217-24. PubMed ID: 10376575
[TBL] [Abstract][Full Text] [Related]
5. Correlation between genito-urinary anomalies, semen analysis and CFTR genotype in patients with congenital bilateral absence of the vas deferens.
de la Taille A; Rigot JM; Mahe P; Vankemmel O; Gervais R; Dumur V; Lemaitre L; Mazeman E
Br J Urol; 1998 Apr; 81(4):614-9. PubMed ID: 9598638
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of cystic fibrosis mutations in infertility patients with DNA sequence analysis.
Danziger KL; Black LD; Keiles SB; Kammesheidt A; Turek PJ
Hum Reprod; 2004 Mar; 19(3):540-6. PubMed ID: 14998948
[TBL] [Abstract][Full Text] [Related]
7. Andrological findings in infertile men with two (biallelic) CFTR mutations: results of a multicentre study in Germany and Austria comprising 71 patients.
Rudnik-Schöneborn S; Messner M; Vockel M; Wirleitner B; Pinggera GM; Witsch-Baumgartner M; Murtinger M; Kliesch S; Swoboda M; Sänger N; Zschocke J; Tüttelmann F
Hum Reprod; 2021 Feb; 36(3):551-559. PubMed ID: 33374015
[TBL] [Abstract][Full Text] [Related]
8. [The analysis of CFTR mutations in men with azoospermia, oligozoospermia and asthenozoospermia].
Slezak R; Szczepaniak M; Pasińska M; Czemarmazowicz H
Ginekol Pol; 2007 Aug; 78(8):605-10. PubMed ID: 18050608
[TBL] [Abstract][Full Text] [Related]
9. Association of cystic fibrosis transmembrane-conductance regulator gene mutation with negative outcome of intracytoplasmic sperm injection pregnancy in cases of congenital bilateral absence of vas deferens.
Lu S; Cui Y; Li X; Zhang H; Liu J; Kong B; Cai F; Chen ZJ
Fertil Steril; 2014 May; 101(5):1255-60. PubMed ID: 24559724
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of genitourinary abnormalities, spermiogram and CFTR genotype in patients with bilateral agenesis of the vas deferens].
de la Taille A; Rigot JM; Mahe P; Gervais R; Dumur V; Lemaitre L; Mazeman E
Prog Urol; 1998 Jun; 8(3):370-6. PubMed ID: 9689669
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of cystic fibrosis transmembrane conductance regulator gene mutations in infertile males.
Schulz S; Jakubiczka S; Kropf S; Nickel I; Muschke P; Kleinstein J
Fertil Steril; 2006 Jan; 85(1):135-8. PubMed ID: 16412743
[TBL] [Abstract][Full Text] [Related]
12. Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracytoplasmic sperm injection.
Tuerlings JH; Mol B; Kremer JA; Looman M; Meuleman EJ; te Meerman GJ; Buys CH; Merkus HM; Scheffer H
Fertil Steril; 1998 May; 69(5):899-903. PubMed ID: 9591500
[TBL] [Abstract][Full Text] [Related]
13. Fructose concentrations in seminal plasma from men with nonobstructive azoospermia.
Buckett WM; Lewis-Jones DI
Arch Androl; 2002; 48(1):23-7. PubMed ID: 11789679
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency of CFTR gene mutations identified in Indian infertile men with non-CBAVD obstructive azoospermia and spermatogenic failure.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Gene; 2014 Sep; 548(1):43-7. PubMed ID: 25010724
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation associated with a congenital bilateral absence of vas deferens.
Sakamoto H; Yajima T; Suzuki K; Ogawa Y
Int J Urol; 2008 Mar; 15(3):270-1. PubMed ID: 18304229
[TBL] [Abstract][Full Text] [Related]
16. Genetic diseases of the seminal ducts.
Meschede D; Dworniczak B; Nieschlag E; Horst J
Biomed Pharmacother; 1998; 52(5):197-203. PubMed ID: 9755815
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia.
Kanavakis E; Tzetis M; Antoniadi T; Pistofidis G; Milligos S; Kattamis C
Mol Hum Reprod; 1998 Apr; 4(4):333-7. PubMed ID: 9620832
[TBL] [Abstract][Full Text] [Related]
18. High frequency of (TG)mTn variant tracts in the cystic fibrosis transmembrane conductance regulator gene in men with high semen viscosity.
Rossi T; Grandoni F; Mazzilli F; Quattrucci S; Antonelli M; Strom R; Lucarelli M
Fertil Steril; 2004 Nov; 82(5):1316-22. PubMed ID: 15533353
[TBL] [Abstract][Full Text] [Related]
19. An overview of CFTR mutation profiles and assisted reproductive technology outcomes in Chinese patients with congenital obstructive azoospermia.
Wang M; Zhou J; Long R; Mao R; Gao L; Wang X; Chen Y; Jin L; Zhu L
J Assist Reprod Genet; 2024 Feb; 41(2):505-513. PubMed ID: 38114870
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermic men and their partners.
Gallati S; Hess S; Galié-Wunder D; Berger-Menz E; Böhlen D
Reprod Biomed Online; 2009 Nov; 19(5):685-94. PubMed ID: 20021716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
